
Meera Natarajan
Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643 |
| Total Applications | 1062 |
| Issued Applications | 625 |
| Pending Applications | 87 |
| Abandoned Applications | 376 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6925398
[patent_doc_number] => 20050238653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system'
[patent_app_type] => utility
[patent_app_number] => 11/107782
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11107782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/107782 | Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system | Apr 17, 2005 | Abandoned |
Array
(
[id] => 7111197
[patent_doc_number] => 20050208652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Isogenic beta-catenin cell lines, and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 11/104063
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13533
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208652.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104063
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104063 | Isogenic beta-catenin cell lines, and methods of making and using same | Apr 10, 2005 | Abandoned |
Array
(
[id] => 7111170
[patent_doc_number] => 20050208625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Monoclonal antibodies with reduced immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 11/099331
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8612
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099331 | Monoclonal antibodies with reduced immunogenicity | Apr 4, 2005 | Abandoned |
Array
(
[id] => 5720367
[patent_doc_number] => 20060073141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Compositions and methods for treating inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 11/098758
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 93372
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073141.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098758
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098758 | Compositions and methods for treating inflammatory disorders | Apr 3, 2005 | Abandoned |
Array
(
[id] => 246752
[patent_doc_number] => 07585503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Method for detecting multi-drug resistance'
[patent_app_type] => utility
[patent_app_number] => 11/094704
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 26
[patent_no_of_words] => 7639
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11094704
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/094704 | Method for detecting multi-drug resistance | Mar 30, 2005 | Issued |
Array
(
[id] => 278117
[patent_doc_number] => 07557193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/593859
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17436
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593859 | Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics | Mar 29, 2005 | Issued |
Array
(
[id] => 4572135
[patent_doc_number] => 07858753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Immunoglobulins'
[patent_app_type] => utility
[patent_app_number] => 10/594293
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 32994
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594293 | Immunoglobulins | Mar 28, 2005 | Issued |
Array
(
[id] => 7168428
[patent_doc_number] => 20050202028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Binding domain-immunoglobulin fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/088693
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26589
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202028.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088693 | Binding domain-immunoglobulin fusion proteins | Mar 22, 2005 | Issued |
Array
(
[id] => 7069514
[patent_doc_number] => 20050244899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody'
[patent_app_type] => utility
[patent_app_number] => 11/079969
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15820
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244899.pdf
[firstpage_image] =>[orig_patent_app_number] => 11079969
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/079969 | Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody | Mar 13, 2005 | Issued |
Array
(
[id] => 7136746
[patent_doc_number] => 20050181479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Periplasmic expression of antibodies using a single signal sequence'
[patent_app_type] => utility
[patent_app_number] => 11/071304
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16907
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071304
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071304 | Periplasmic expression of antibodies using a single signal sequence | Mar 3, 2005 | Abandoned |
Array
(
[id] => 5682960
[patent_doc_number] => 20060199230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Use of prostate specific antigen to predict drug response'
[patent_app_type] => utility
[patent_app_number] => 11/072854
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10933
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11072854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/072854 | Use of prostate specific antigen to predict drug response | Mar 2, 2005 | Abandoned |
Array
(
[id] => 5224688
[patent_doc_number] => 20070253954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Epha4 As Therapeutic Target Of Prc And Pdaca'
[patent_app_type] => utility
[patent_app_number] => 10/590801
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22001
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590801 | Epha4 As Therapeutic Target Of Prc And Pdaca | Feb 17, 2005 | Abandoned |
Array
(
[id] => 5159856
[patent_doc_number] => 20070172900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Diagnostic marker for cancer'
[patent_app_type] => utility
[patent_app_number] => 10/589487
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13203
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589487 | Diagnostic marker for cancer | Feb 15, 2005 | Abandoned |
Array
(
[id] => 4909642
[patent_doc_number] => 20080020408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Anti-Ube4a/Ufd2b Polyclonal Antibody and Its Use Thereof as Diagnostic and Prognostic Marker of 11Q23 Region Alterations'
[patent_app_type] => utility
[patent_app_number] => 10/589299
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3497
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589299 | Anti-Ube4a/Ufd2b Polyclonal Antibody and Its Use Thereof as Diagnostic and Prognostic Marker of 11Q23 Region Alterations | Feb 7, 2005 | Abandoned |
Array
(
[id] => 7050299
[patent_doc_number] => 20050186186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Compositions for eliciting immune response and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 11/045357
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5419
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186186.pdf
[firstpage_image] =>[orig_patent_app_number] => 11045357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/045357 | Compositions for eliciting immune response and methods for using same | Jan 30, 2005 | Abandoned |
Array
(
[id] => 5738467
[patent_doc_number] => 20060008858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone'
[patent_app_type] => utility
[patent_app_number] => 11/046666
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7336
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11046666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/046666 | Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone | Jan 27, 2005 | Abandoned |
Array
(
[id] => 5903175
[patent_doc_number] => 20060046257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 11/051720
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 249848
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051720 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | Jan 26, 2005 | Issued |
Array
(
[id] => 4988113
[patent_doc_number] => 20070154452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Therapeutic agent for pancreas cancer'
[patent_app_type] => utility
[patent_app_number] => 10/597206
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597206 | Therapeutic agent for pancreas cancer | Jan 25, 2005 | Abandoned |
Array
(
[id] => 602594
[patent_doc_number] => 07432357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Anti-cancer antibodies with reduced complement fixation'
[patent_app_type] => utility
[patent_app_number] => 11/040071
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 5492
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432357.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040071
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040071 | Anti-cancer antibodies with reduced complement fixation | Jan 20, 2005 | Issued |
Array
(
[id] => 5435579
[patent_doc_number] => 20090170166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'ANTIBODY INHIBITING URACIL-DNA-GLYCOSYLASE AND USES THEREOF FOR DECONTAMINATING NUCLEIC ACID AMPLIFICATION REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 10/596965
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4603
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596965 | ANTIBODY INHIBITING URACIL-DNA-GLYCOSYLASE AND USES THEREOF FOR DECONTAMINATING NUCLEIC ACID AMPLIFICATION REACTIONS | Dec 21, 2004 | Abandoned |